Načítá se...
Cost-effectiveness of cervical cancer screening with primary HPV testing for unvaccinated women in Sweden
BACKGROUND: Sweden revised their cervical cancer screening program in 2017 to include cytology-based screening for women aged 23–29 years and primary human papillomavirus (HPV) testing for women aged 30–64 years; however, alternative strategies may be preferred. To inform cervical cancer prevention...
Uloženo v:
| Vydáno v: | PLoS One |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Public Library of Science
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7526933/ https://ncbi.nlm.nih.gov/pubmed/32997696 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0239611 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|